Olumniant (barcitinab) from Eli Lilly gets EUA from US FDA for COVID-19 treatment
Baricitinib is an FDA-approved drug to treat rheumatoid arthritis
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
arthritis drug
Scientists to investigate arthritis drug as potential therapy for vascular dementia
New funding by the British Heart Foundation awarded to the Universities of Sheffield and Manchester to investigate the link…
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial
The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe…